Carisma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
CARM Key Statistics
Market cap104.61K
Market cap104.61K
Price-Earnings ratio0.01
Price-Earnings ratio0.01
Dividend yield—
Dividend yield—
Average volume8.63K
Average volume8.63K
High today—
High today—
Low today—
Low today—
Open price$0.0022
Open price$0.0022
Volume0.00
Volume0.00
52 Week high$0.556
52 Week high$0.556
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
With a market cap of 104.61K, Carisma Therapeutics(CARM) trades at $0.00. The stock has a price-to-earnings ratio of 0.01.
During the trading day, Carisma Therapeutics(CARM) stock saw an opening price of $0.00, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 8.63K.
Over the past 52 weeks, Carisma Therapeutics(CARM) stock has traded between a high of $0.56 and a low of $0.00.
Over the past 52 weeks, Carisma Therapeutics(CARM) stock has traded between a high of $0.56 and a low of $0.00.
People also own
Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.